Merck | MRK - Equity Capital And Reserves


Merck reported EUR29.74B in Equity Capital and Reserves for its fiscal quarter ending in March of 2026.





Equity Capital And Reserves Change Date
Adidas EUR 5.99B 211M Mar/2026
Adyen EUR 5.29B 610.33M Dec/2025
Akzo Nobel EUR 4.88B 222M Mar/2026
Alcon AG USD 22.13B 99M Mar/2026
Amadeus IT EUR 4.8B 49.7M Mar/2026
Amarin USD 449.41M 9.87M Mar/2026
AstraZeneca USD 47.33B 1.33B Mar/2026
BASF EUR 33.2B 434M Dec/2025
Bayer EUR 28.85B 2.9B Mar/2026
Beiersdorf EUR 8.6B 133M Dec/2025
Covestro EUR 7B 908M Dec/2025
Danone EUR 16.92B 1.56B Dec/2025
Fresenius EUR 19.77B 1.14B Dec/2025
Fresenius Medical Care EUR 14.2B 13.95B Mar/2026
Genmab DKK 5.85B 96M Dec/2025
Givaudan CHF 4.54B 430M Dec/2025
GlaxoSmithKline GBP 17.42B 1.05B Mar/2026
GRIFOLS EUR 5.46B 171M Mar/2026
Henkel EUR 20.5B 459M Dec/2025
Hikma Pharmaceutical USD 2.59B 42M Dec/2025
Infineon EUR 16.8B 648M Mar/2026
Lakefront Biotherapeutics EUR 3.25B 17.5M Mar/2026
Linde USD 40.09B 1.85B Mar/2026
Lonza CHF 9.13B 513M Dec/2025
Merck EUR 29.74B 1.15B Mar/2026
Novartis USD 38.93B 7.2B Mar/2026
Philips EUR 11.39B 403M Mar/2026
Roche Holding CHF 33.8B 758M Dec/2025
Sanofi EUR 72.81B 1.1B Mar/2026
UCB EUR 10.87B 1.18B Dec/2025